학술논문
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
Document Type
Article
Author
Tukhvatulin, A.I.; Dolzhikova, I.V.; Shcheblyakov, D.V.; Zubkova, O.V.; Dzharullaeva, A.S.; Kovyrshina, A.V.; Lubenets, N.L.; Grousova, D.M.; Erokhova, A.S.; Botikov, A.G.; Izhaeva, F.M.; Popova, O.; Ozharovskaia, T.A.; Esmagambetov, I.B.; Favorskaya, I.A.; Zrelkin, D.I.; Voronina, D.V.; Shcherbinin, D.N.; Semikhin, A.S.; Simakova, Y.V.; Tokarskaya, E.A.; Shmarov, M.M.; Nikitenko, N.A.; Gushchin, V.A.; Naroditsky, B.S.; Logunov, D.Y.; Gintsburg, A.L.; Smolyarchuk, E.A.; Zubkova, T.G.; Zakharov, K.A.; Vasilyuk, V.B.; Borisevich, S.V.
Source
In: The Lancet Regional Health - Europe . (The Lancet Regional Health - Europe, December 2021, 11)
Subject
Language
English
ISSN
26667762